- Home
- / PsyBio Therapeutics
PsyBio Therapeutics
Stock Price
$0
2024-04-05
Market Capitalization
$1.3 M
2024-04-05
PsyBio Therapeutics Summary
Company Summary
- Overview
- PsyBio Therapeutics is a biotechnology company that develops psychoactive pharmaceutical products. It offers biosynthetic psychedelic compounds for the treatment of mental and neurological health disorders.
- Type
- Public
- Status
- Active
- Founded
- 2020
- Website
- https://www.psybiolife.com
- Cybersecurity rating
Table of Contents
PsyBio Therapeutics Financials
Summary Financials
- Net income (Q2, 2023)
- ($145.0K)
- Cash (Q2, 2023)
- $12.0K
- EBIT (Q2, 2023)
- ($92.0K)
- Enterprise value
- $1.3M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026